• File Size 1,016.42 KB
• File Count 1
• Create Date January 28, 2025
• Last Updated January 28, 2025

Q4 2024 Zoetis Valuation Analysis

Zoetis Inc. is a global leader in the development, production, and commercialization of animal health products. Founded in 1952 as a division of Pfizer, Zoetis became an independent company in 2013, when it was spun off from Pfizer. Headquartered in Parsippany, New Jersey, Zoetis operates in over 100 countries and is a key player in the animal health industry, providing a wide range of pharmaceutical, diagnostic, and vaccine products for both livestock and pets. Zoetis' product portfolio includes vaccines, anti-infective agents, parasiticides, and other therapeutic treatments. The company focuses on the health of food-producing animals such as cattle, poultry, and swine, as well as companion animals like dogs, cats, and horses.